Delayed graft function: A frequent but still unsolved problem in renal transplantation;La reprise retardée de fonction: Une complication fréquente, non résolue, en transplantation rénale

Nephrologie et Therapeutique

Volumn 1, Issue 6, 2005, Pages 325-334

  Szwarc, Ilan ^a   Garrigue, Valérie ^a   Delmas, Sylvie ^a   Deleuze, Sébastien ^a   Chong, Guillaume ^a   Mourad, Georges ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Delayed graft function; Ischemia reperfusion; Kidney transplantation

Indexed keywords

CADAVER KIDNEY; ECONOMIC ASPECT; GRAFT SURVIVAL; HEMODIALYSIS; HEMODYNAMIC MONITORING; HOSPITALIZATION; HUMAN; ISCHEMIA; KIDNEY ALLOGRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

EID: 29744440733     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2005.08.003     Document Type: Short Survey

References (63)

1. Salahudeen AK, Haider N, May W. Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 2004;65:713-8.
2. Kuypers DR, Chapman JR, O'Connell PJ, Allen RD, Nankivell BJ. Predictors of renal transplant histology at three months. Transplantation 1999;67:1222-30.
3. Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, Bear RA, Cole EH, Fenton SS, Cattran DC. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988;46:223-8.
4. Govani MV, Kwon O, Batiuk TD, Milgrom ML, Filo RS. Creatinine reduction ratio and 24-hour creatinine excretion on posttransplant day two: simple and objective tools to define graft function. J Am Soc Nephrol 2002;13:1645-9.
5. Giral-Classe M, Hourmant M, Cantarovich D, Dantal J, Blanche G, Daguin P, Ancelet D, Soulillou JP. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998;54:972-8.
6. Ojo AO, Leichtman AB, Punch JD, Hanson JA, Dickinson DM, Wolfe RA, et al. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Am J Kidney Dis 2000;36(1):153-9.
7. Halloran PF, Hunsicker LG. Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001;1:115-20.
8. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63:968-74.
9. Snyder JJ, Kasiske BL, Gilbertson DT, Collins AJ. A comparison of transplant outcomes in peritoneal and hemodialysis patients. Kidney Int 2002;6:1423-30.
10. Thomas MC, Mathew TH, Russ GR, Rao MM, Moran J. Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Transplantation 2003;75:1989-95.
11. Gastaldello K, Melot C, Kahn RJ, Vanherweghem JL, Vincent JL, Tielemans C. Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study. Nephrol Dial Transplant 2000;15(2):224-30.
12. Romao Jr. JE, Abensur H, de Castro MC, Ianhez LE, Massola VC, Sabbaga E. Effect of dialyser biocompatibility on recovery from acute renal failure after cadaver renal transplantation. Nephrol Dial Transplant 1999;14(3):709 12.
13. Sutton TA, Fisher CJ, Molitoris BA. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002;62:1539-49.
14. Molitoris BA. Actin cytoskeleton in ischemic acute renal failure. Kidney Int 2004;66:871-83.
15. Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease? Kidney Int 2004;66:480-5.
16. Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med 1996;334:1448-60.
17. Navarro P, Caveda L, Breviario F, Mandoteanu I, Lampugnani MG, Dejana E. Catenin-dependent and independent functions of vascular endothelial cadherin. J Biol Chem 1995;270:30965-72.
18. Brodsky SV, Yamamoto T, Tada T, Kim B, Chen J, Kajiya F, Goligorsky MS. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002;282:F1140-F1149.
19. Hellberg PO, Kallskog OT, Ojteg G, Wolgast M. Peritubular capillary permeability and intravascular RBC aggregation after ischemia: effects of neutrophils. Am J Physiol 1990;258:F1018-F1025.
20. Haugen E, Nath KA. The involvement of oxidative stress in the progression of renal injury. Blood Purif 1999;17:58-65.
21. Bilzer M, Gerbes AL. Preservation injury of the liver: mechanisms and novel therapeutic strategies. J Hepatol 2000;32:508-15.
22. Kaushal GP, Basnakian AG, Shah SV. Apoptotic pathways in ischemic acute renal failure. Kidney Int 2004;66:500-6.
23. Zimmerman BJ, Granger DN. Mechanisms of reperfusion injury. Am J Med Sci 1994;307:284-92.
24. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol Ther 2001;89:29-46.
25. Donnahoo KK, Meng X, Ayala A, Cain MP, Harken AH, Meldrum DR. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am J Physiol 1999;277:R922-R929.
26. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int 2004;66:486-91.
27. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol 1996;155:1831-40.
28. Daha MR, van Kooten C. Is the proximal tubular cell a pro-inflammatory cell? Nephrol Dial Transplant 2000;15(Suppl 6):41-3.
29. Li H, Nord EP. CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am J Physiol Renal Physiol 2002;282: F1020-F1033.
30. Segerer S, Cui Y, Hudkins KL, Goodpaster T, Eitner F, Mack M, et al. Expression of the chemokine monocyte chemoattractant protein-1 and its receptor chemokine receptor 2 in human crescentic glomerulonephritis. J Am Soc Nephrol 2000;11:2231-42.
31. Deckers JG, De Haij S, van der Woude FJ, van der Kooij SW, Daha MR, van Kooten C. IL-4 and IL-13 augment cytokine- and CD40-induced RANTES production by human renal tubular epithelial cells in vitro. J Am Soc Nephrol 1998;9:1187-93.
32. Wang S, Hirschberg R. Role of growth factors in acute renal failure. Nephrol Dial Transplant 1997;12:1560-3.
33. Lieberthal W, Nigam SK. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am J Physiol Renal Physiol 2000;278:F1-F12.
34. Maeshima A, Yamashita S, Nojima Y. Identification of renal progenitor-like tubular cells that participate in the regeneration processes of the kidney. J Am Soc Nephrol 2003;14:3138-46.
35. Lin F, Cordes K, Li L, Hood L, Couser WG, Shankland SJ, et al. Hematopoietic stem cells contribute to the regen-eration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol 2003;14:1188-99.
36. Oliver JA, Maarouf O, Cheema FH, Martens TP, Al-Awqati Q. The renal papilla is a niche for adult kidney stem cells. J Clin Invest 2004;114:795-804.
37. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993;49:481-93.
38. Nicholson M, Wheathley J, Horsburgh T, Edwards CM, Veitch PS, Bell PR. The relative influence of delayed graft function and acute rejection on renal transplantation survival. Transplant Int 1996;9:415-9.
39. Rocher LL, Landis C, Dafoe DC, Keyserling C, Swartz RD, Campbell Jr. DA. The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients. Transplant Proc 1987;19:2093-5.
40. Barry JM, Shively N, Hubert B, Hefty T, Norman DJ, Bennett WM. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants. Transplantation 1988;45:346-8.
41. Cacciarelli T, Sumrani N, Delaney V, Hong JH, DiBenedetto A, Sommer BG. The influence of delayed renal allograft function on long-term outcome in the cyclosporine era. Clin Nephrol 1993;39:335-9.
42. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, Matas AJ. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation 1995;59:962-8.
43. Troppmann C, Gillingham KJ, Gruessner RW, Dunn DL, Payne WD, Najarian JS, Matas AJ. Delayed graft function in the absence of rejection has no long-term impact. A study of cadaver kidney recipients with good graft function at 1 year after transplantation. Transplantation 1996;61:1331-7.
44. Troppmann C, Gruessner AC, Gillingham KJ, Sutherland DE, Matas AJ, Gruessner RW. Impact of delayed function on long-term graft survival after solid organ transplantation. Transplant Proc 1999;31:1290-2.
45. Cecka JM. The UNOS Scientific Renal Transplant Registry-2000. Clin Transpl 20001-18.
46. Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984;38:643-8.
47. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000;58:859-66.
48. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000;11:565 73.
49. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004;364:1814-27.
50. Hernandez A, Light JA, Barhyte DY, Mabudian M, Gage F. Ablating the ischemia-reperfusion injury in non-heart-beating donor kidneys. Transplantation 1999;67:200-6.
51. Faenza A, Catena F, Nardo B, Montalti R, Capocasale E, Busi N, et al. Kidney preservation with university of Wisconsin and Celsior solution: a prospective multicenter randomized study. Transplantation 2001;72:1274-7.
52. de Boer J, De Meester J, Smits JM, Groenewoud AF, Bok A, van der Velde O, et al. Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl Int 1999;12:447-53.
53. Hauet T, Goujon JM, Vandewalle A, Baumert H, Lacoste L, Tillement JP, et al. Trimetazidine reduces renal dysfunction by limiting the cold ischemia-reperfusion injury in autotransplanted pig kidneys. J Am Soc Nephrol 2000;11:138-48.
54. Ahlenstiel T, Burkhardt G, Kohler H, Kuhlmann MK. Bioflavonoids attenuate renal proximal tubular cell injury during cold preservation in Euro-Collins and University of Wisconsin solutions. Kidney Int 2003;63:554-63.
55. Dragun D, Tullius SG, Park JK, Maasch C, Lukitsch I, Lippoldt A, et al. ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation. Kidney Int 1998;54:590-602.
56. Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins LE, et al. A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 1999;67:729-36.
57. Casilli F, Bianchini A, Bertini R. Inhibition of interteukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokin receptors CXCR1 and CXCR2. Biochem Pharmacol 2005;69:385-94.
58. Chandraker A, Takada M, Nadeau KC, Peach R, Tilney NL, Sayegh MH. CD28-b7 blockade in organ dysfunction secondary to cold ischemia-reperfusion injury. Kidney Int 1997;52:1678-84.
59. Mister M, Noris M, Szymczuk J. Propionyl-L-Carnitine prevent renal function deterioration due to ischemia-reperfusion. Kidney Int 2002;61:1064-78.
60. Chatterjee PK, Patel NSA, Sivarajah A, Krale EO, Dugo L, Cuzzocrea S, et al. GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia-reperfusion injury. Kidney Int 2003;63:853-65.
61. Hirschberg R, Kopple J, Lipsett P, Benjamin E, Minei J, Albertson T, et al. Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure. Kidney Int 1999;55:2423-32.
62. Yokota N, O'Donnell M, Daniels F, Burne-Taney M, Keane W, Kasiske B, et al. Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury. Am J Nephrol 2003;23:13-7.
63. Ricard-Sutra E, Garrigue V, Bismuth J, Chong G, Argiles A, Mourad G. Sequential protocols with thymoglobuline and delayed introduction of calcineurin: effects on renal function in renal transplant recipients with non immunological risk and low risk of delayed graft function. Nephrologie 2004;25:127-32.